We reiterate unless and until the zone of 11,565-11,585 is pierced convincingly; don't expect a runaway rise. With the indices being trapped in a range, there are not clear opportunities for traders in the index; however, ample traction is seen in the broader markets.

A decisive trend could be seen only if Nifty breaks above the resistance of 11,565-11,585 while on the downside, close below the 11,300 levels. Stocks in news: Aurobindo Pharma, Wipro, Sterlite Technologies, Infosys, Indo Count, REC.

The relationship between the spot price of the underlying and the strike price is described by the moneyness of an option.

Nila Infrastructures Ltd, a penny stock in the infrastructure space outperformed in today's session by gaining 7.29 per cent with increasing volumes. The stock is up by 24 per cent on a YTD basis. 

This pattern indicates a day with low volatility and a small range. And according to Toby Crabel, the low level of volatility is often followed by a sudden increase in the volatility and a directional move.

On Tuesday, the markets experienced sideways improvement with active gains in the broader markets. Sensex closed at 39,044.35, gaining by 287.72 points or 0.74 per cent while Nifty rose by 81.75 points or 0.71 per cent to close at 11,521.80.

JB Chemicals & Pharmaceuticals emerged as one of the top pharmaceuticals stock gainers on Tuesday. The stock jumped more than 16 per cent and made a new 52-week high of Rs 965 on BSE.

The option premium (i.e. the price of the calls and puts that you see on your trading screen) has two components:

The retail inflation has soared beyond Reserve Bank of India’s (RBI) upper margin of 6 per cent. The Indian central bank has been instructed by the government to keep the inflation within the range of 4 per cent with a margin of 2 per cent on either side.

The broader market is witnessing a rally due to the proposed changes in SEBI’s guidelines for the multi-cap category. You should continue with your investment and stick to your asset allocation.